{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":18,"n_cols":5,"rows_kept":18,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[5,2,5,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[12,2,12,3],[13,2,13,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910133361403321"]
[null,null,"Autore",null,"Doulaye Sacko"]
[null,null,"Titolo",null,"Lutte contre le trachome en Afrique subsaharienne"]
[null,null,"Pubbl/distr/stampa",null,"IRD Éditions, 2006"]
[{"$nulls":4},"[Place of publication not identified], : IRD Éditions, 2006"]
[null,null,"ISBN",null,"9782709917735"]
[{"$nulls":4},"2709917734"]
[null,null,"Descrizione fisica",null,"1 online resource (296 pages)"]
[null,null,"Collana",null,"Collection  Expertise collégiale"]
[null,null,"Soggetti",null,"Medicine"]
[{"$nulls":4},"Health & Biological Sciences"]
[{"$nulls":4},"Ophthalmology & Optometry"]
[null,null,"Lingua di pubblicazione",null,"Francese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Bibliographic Level Mode of Issuance: Monograph"]
[null,null,null,"Sommario/riassunto","Le trachome, la maladie des « cils qui poussent à l’intérieur », est la deuxième cause de cécité dans le monde. Bien qu’elle soit susceptible d’être prévenue et traitée, elle frappe encore près de 80 millions de personnes, en particulier dans le sud du Sahara. Quelles sont les causes de cette maladie ? Comment y faire face ? Comment évaluer le succès des actions préventives ou curatives déjà entreprises ? Où en est la lutte contre cette infection et quelles sont les recommandations nécessaires à son éradication ? Cette expertise collégiale menée par l’IRD, réalisée par une quinzaine de chercheurs à la demande du ministère de la Santé du Mali et de l’Institut d’ophtalmologie tropicale d’Afrique (Mali), s’attache à décrire l’état actuel de la lutte contre cette conjonctivite cécitante d’origine infectieuse. En dressant le bilan des stratégies déjà à l’œuvre, notamment celle du programme CHANCE de l’OMS, cette expertise cherche à définir les conditions et les perspectives de cette maladie.  Trachoma, the disease of the “eyelashes which turn inward”, is the second cause of blindness in the world. Although it can be predicted and treated, it still affects nearly 80 million people, particularly in the South Sahara. What are the causes of this disease? How can it be combated? How can the success of preventative and curative actions already undertaken be evaluated? What is the current situation in the fight against this infection and what lessons can be drawn? This IRD Expert Group Review, conducted by "]
[{"$nulls":4},"more than a dozen researchers at the request of the Malian Health Ministry and the Institut d’ophtalmologie tropicale de l’Afrique in Bamako, describes the current situation in the fight against this blinding conjunctivitis of infectious origin. By evaluating the strategies already deployed – particularly the WHO SAFE strategy – it seeks to define the conditions and prospects for its eradication."]